Found: 180
Select item for more details and to access through your institution.
Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Extrapulmonary small cell carcinoma: Single center experience with 61 patients.
- Published in:
- Acta Oncologica, 2007, v. 46, n. 6, p. 846, doi. 10.1080/02841860601071893
- By:
- Publication type:
- Article
Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: A Korean Cancer Study Group Trial.
- Published in:
- Acta Oncologica, 2005, v. 44, n. 3, p. 230, doi. 10.1080/02841860510029590
- By:
- Publication type:
- Article
Phase II Study of Gemcitabine, UFT and Leucovorin in Patients with Advanced Pancreatic Cancer.
- Published in:
- Acta Oncologica, 2002, v. 41, n. 7/8, p. 689, doi. 10.1080/028418602321028328
- By:
- Publication type:
- Article
Response to imatinib rechallenge in a patient with a recurrent gastrointestinal stromal tumor after adjuvant therapy: a case report.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, p. 362, doi. 10.1245/s10434-015-4506-3
- By:
- Publication type:
- Article
Intraoperatively Assessed Macroscopic Serosal Changes in Patients with Curatively Resected Advanced Gastric Cancer: Clinical Implications for Prognosis and Peritoneal Recurrence.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 9, p. 2940, doi. 10.1245/s10434-014-4352-8
- By:
- Publication type:
- Article
The Role of Surgical Resection Following Imatinib Treatment in Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 13, p. 4211, doi. 10.1245/s10434-014-3866-4
- By:
- Publication type:
- Article
The Effects of Surgical Cytoreduction Prior to Imatinib Therapy on the Prognosis of Patients with Advanced GIST.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 13, p. 4212, doi. 10.1245/s10434-013-3279-9
- By:
- Publication type:
- Article
Neoadjuvant Docetaxel, Capecitabine and Cisplatin (DXP) in Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2010, v. 17, n. 4, p. 1024, doi. 10.1245/s10434-009-0838-1
- By:
- Publication type:
- Article
Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2013, v. 9, n. 4, p. 324, doi. 10.1111/ajco.12019
- By:
- Publication type:
- Article
Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2009, v. 5, n. 2, p. 95, doi. 10.1111/j.1743-7563.2009.01198.x
- By:
- Publication type:
- Article
Impact of l-carnitine on imatinib-related muscle cramps in patients with gastrointestinal stromal tumor.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 493, doi. 10.1007/s10637-019-00860-x
- By:
- Publication type:
- Article
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 2, p. 180, doi. 10.1007/s10637-016-0407-y
- By:
- Publication type:
- Article
Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 743, doi. 10.4143/crt.2023.980
- By:
- Publication type:
- Article
GASTric Cancer HER2 Re-Assessment Study 2 (GASTHER2): HER2 Re-assessment for Initially HER2-Negative Advanced Gastric Cancer Patients after Progression on First-Line Treatment.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 1, p. 199, doi. 10.4143/crt.2023.490
- By:
- Publication type:
- Article
Adjuvant Imatinib Treatment for 5 Years versus 3 Years in Patients with Ruptured Localized Gastrointestinal Stromal Tumor: A Retrospective Analysis.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1167, doi. 10.4143/crt.2021.1040
- By:
- Publication type:
- Article
Trends in Chemotherapy Patterns and Survival of Patients with Advanced Gastric Cancer over a 16-Year Period: Impact of Anti-HER2-Targeted Agent in the Real-World Setting.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 2, p. 436, doi. 10.4143/crt.2020.725
- By:
- Publication type:
- Article
Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 4, p. 851, doi. 10.4143/crt.2016.176
- By:
- Publication type:
- Article
Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 2, p. 350, doi. 10.4143/crt.2016.067
- By:
- Publication type:
- Article
Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1155, doi. 10.4143/crt.2016.187
- By:
- Publication type:
- Article
Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 546, doi. 10.4143/crt.2015.015
- By:
- Publication type:
- Article
Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 1, p. 162, doi. 10.4143/crt.2015.017
- By:
- Publication type:
- Article
Current Status and Challenges of Cancer Clinical Trials in Korea.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 1, p. 20, doi. 10.4143/crt.2014.317
- By:
- Publication type:
- Article
Clinical Practice Guideline for Accurate Diagnosis and Effective Treatment of Gastrointestinal Stromal Tumor in Korea.
- Published in:
- Cancer Research & Treatment, 2012, v. 44, n. 2, p. 85, doi. 10.4143/crt.2012.44.2.85
- By:
- Publication type:
- Article
Recent Advances in Chemotherapy for Advanced Gastric Cancer.
- Published in:
- Asia Pacific Journal of Oncology & Hematology, 2010, v. 2, n. 1, p. 67
- By:
- Publication type:
- Article
Impact of systemic steroids on the efficacy of first line imatinib treatment of patients with advanced gastrointestinal stromal tumors (GISTs).
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-13032-9
- By:
- Publication type:
- Article
Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2934-5
- By:
- Publication type:
- Article
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 4, p. 175
- By:
- Publication type:
- Article
Unmet needs of non-Hodgkin lymphoma survivors in Korea: prevalence, correlates, and associations with health-related quality of life.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical and histopathologic analysis of 46 cases of cutaneous adverse reactions to imatinib.
- Published in:
- International Journal of Dermatology, 2016, v. 55, n. 5, p. e268, doi. 10.1111/ijd.13111
- By:
- Publication type:
- Article
Perioperative treatments for resectable gastric cancer.
- Published in:
- Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi, 2015, v. 58, n. 3, p. 201, doi. 10.5124/jkma.2015.58.3.201
- By:
- Publication type:
- Article
FGFR2 Assessment in Gastric Cancer Using Quantitative Real-Time Polymerase Chain Reaction, Fluorescent In Situ Hybridization, and Immunohistochemistry.
- Published in:
- American Journal of Clinical Pathology, 2015, v. 143, n. 6, p. 865, doi. 10.1309/AJCPNFLSMWWPP8DR
- By:
- Publication type:
- Article
A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Primary Central Nervous System Marginal Zone B-Cell Lymphoma of the Basal Ganglia Mimicking Low-Grade Glioma: A Case Report and Review of the Literature.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 5, p. 305
- By:
- Publication type:
- Article
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG).
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10642-7
- By:
- Publication type:
- Article
A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 355, doi. 10.1007/s10637-013-0057-2
- By:
- Publication type:
- Article
Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 271, doi. 10.1007/s10637-013-9983-2
- By:
- Publication type:
- Article
Efficacy, safety, and pharmacokinetics of imatinib dose escalation to 800 mg/day in patients with advanced gastrointestinal stromal tumors.
- Published in:
- 2013
- By:
- Publication type:
- Report
A phase I study of DHP107, a mucoadhesive lipid form of oral paclitaxel, in patients with advanced solid tumors: Crossover comparisons with intravenous paclitaxel.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 616, doi. 10.1007/s10637-012-9841-7
- By:
- Publication type:
- Article
Changes in imatinib plasma trough level during long-term treatment of patients with advanced gastrointestinal stromal tumors: correlation between changes in covariates and imatinib exposure.
- Published in:
- 2012
- By:
- Publication type:
- Report
Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory and KRAS wild-type metastatic colorectal cancer according to epidermal growth factor receptor expression status.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1607, doi. 10.1007/s10637-011-9703-8
- By:
- Publication type:
- Article
Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patients.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 819, doi. 10.1007/s10637-010-9593-1
- By:
- Publication type:
- Article
Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 1, p. 306, doi. 10.1007/s10637-010-9531-2
- By:
- Publication type:
- Article
Phase II study of sunitinib as second-line treatment for advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 6, p. 1449, doi. 10.1007/s10637-010-9438-y
- By:
- Publication type:
- Article
A phase I study of S-1 treatment with a 3 week schedule in advanced biliary cancer patients with or without hepatic dysfunction.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 332, doi. 10.1007/s10637-009-9378-6
- By:
- Publication type:
- Article
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 366, doi. 10.1007/s10637-009-9363-0
- By:
- Publication type:
- Article
Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2006, v. 99, n. 1, p. 9, doi. 10.1007/s10549-006-9175-2
- By:
- Publication type:
- Article
Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 4, p. 440, doi. 10.1159/000506946
- By:
- Publication type:
- Article
Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE).
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 7784, doi. 10.1002/cam4.5536
- By:
- Publication type:
- Article